NCT02472782View on ClinicalTrials.gov

Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication

CompletedOBSERVATIONAL
Enrollment

851

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

December 15, 2018

Conditions
Osteoporosis, PostmenopausalOsteoporosis, Steroid Induced
Interventions
DRUG

Teriparatide

The study will include patients from pre-defined groups of individuals (postmenopausal, male, and steroid-induced osteoporosis) who would any way receive teriparatide for their condition according to standard medical practice and Greek treatment guidelines

Trial Locations (1)

11525

251 Hellenic Air Force & VA General Hospital, Athens

All Listed Sponsors
collaborator

Hellenic Osteoporosis Foundation (www.http://heliost.gr/en/)

UNKNOWN

lead

251 Hellenic Air Force & VA General Hospital

OTHER

NCT02472782 - Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication | Biotech Hunter | Biotech Hunter